BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ford EC, Herman J, Yorke E, Wahl RL. 18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy. J Nucl Med 2009;50:1655-65. [PMID: 19759099 DOI: 10.2967/jnumed.108.055780] [Cited by in Crossref: 105] [Cited by in F6Publishing: 85] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Tejpal G, Jaiprakash A, Susovan B, Ghosh-Laskar S, Murthy V, Budrukkar A. IMRT and IGRT in head and neck cancer: Have we delivered what we promised? Indian J Surg Oncol 2010;1:166-85. [PMID: 22930632 DOI: 10.1007/s13193-010-0030-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
2 Price PM, Green MM. Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments. Br J Radiol 2011;84 Spec No 1:S19-34. [PMID: 21427180 DOI: 10.1259/bjr/21263014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
3 Uppal R, Catana C, Ay I, Benner T, Sorensen AG, Caravan P. Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe--feasibility study in rat model. Radiology 2011;258:812-20. [PMID: 21177389 DOI: 10.1148/radiol.10100881] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
4 Beyer T, Townsend DW, Czernin J, Freudenberg LS. The future of hybrid imaging-part 2: PET/CT. Insights Imaging 2011;2:225-34. [PMID: 23099865 DOI: 10.1007/s13244-011-0069-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
5 Nunna P, Sheikhbahaei S, Ahn S, Young B, Subramaniam RM. The Role of Positron Emission Tomography/Computed Tomography in Management and Prediction of Survival in Pancreatic Cancer: . Journal of Computer Assisted Tomography 2016;40:142-51. [DOI: 10.1097/rct.0000000000000323] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kao CH, Hsieh TC, Yu CY, Yen KY, Yang SN, Wang YC, Liang JA, Chien CR, Chen SW. 18F-FDG PET/CT-based gross tumor volume definition for radiotherapy in head and neck cancer: a correlation study between suitable uptake value threshold and tumor parameters. Radiat Oncol 2010;5:76. [PMID: 20813064 DOI: 10.1186/1748-717X-5-76] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Brændengen M, Hansson K, Radu C, Siegbahn A, Jacobsson H, Glimelius B. Delineation of Gross Tumor Volume (GTV) for Radiation Treatment Planning of Locally Advanced Rectal Cancer Using Information From MRI or FDG-PET/CT: A Prospective Study. International Journal of Radiation Oncology*Biology*Physics 2011;81:e439-45. [DOI: 10.1016/j.ijrobp.2011.03.031] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
8 Takei T, Shiga T, Morimoto Y, Takeuchi W, Umegaki K, Matsuzaki K, Okamoto S, Magota K, Hara T, Fukuda S, Tamaki N. A novel PET scanner with semiconductor detectors may improve diagnostic accuracy in the metastatic survey of head and neck cancer patients. Ann Nucl Med 2013;27:17-24. [PMID: 23124525 DOI: 10.1007/s12149-012-0654-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
9 Ye JC, Truong M, Kachnic LA, Subramaniam RM, Hirsch AE. Implications of previously undetected incidental findings on 3D CT simulation scans for radiation therapy. Practical Radiation Oncology 2011;1:22-6. [DOI: 10.1016/j.prro.2010.09.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Yokouchi M, Terahara M, Nagano S, Arishima Y, Zemmyo M, Yoshioka T, Tanimoto A, Komiya S. Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma. BMC Musculoskelet Disord 2011;12:166. [PMID: 21774838 DOI: 10.1186/1471-2474-12-166] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
11 Kobayashi H, Longmire MR, Ogawa M, Choyke PL, Kawamoto S. Multiplexed imaging in cancer diagnosis: applications and future advances. Lancet Oncol 2010;11:589-95. [PMID: 20338808 DOI: 10.1016/S1470-2045(10)70009-7] [Cited by in Crossref: 59] [Cited by in F6Publishing: 20] [Article Influence: 4.9] [Reference Citation Analysis]
12 Yeh R, Dercle L, Garg I, Wang ZJ, Hough DM, Goenka AH. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma. Abdom Radiol (NY). 2018;43:415-434. [PMID: 29143875 DOI: 10.1007/s00261-017-1374-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 10.3] [Reference Citation Analysis]
13 Schiepers C, Dahlbom M. Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging. Eur Radiol 2011;21:548-54. [PMID: 21174096 DOI: 10.1007/s00330-010-2033-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
14 Ren S, Zhu X, Zhang A, Li D, Zuo C, Zhang H. Prognostic value of 18F-FDG PET /CT metabolic parameters in patients with locally advanced pancreatic Cancer treated with stereotactic body radiation therapy. Cancer Imaging 2020;20:22. [PMID: 32156306 DOI: 10.1186/s40644-020-00301-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Coffey M, Vaandering A. Patient setup for PET/CT acquisition in radiotherapy planning. Radiotherapy and Oncology 2010;96:298-301. [DOI: 10.1016/j.radonc.2010.07.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
16 Dholakia AS, Chaudhry M, Leal JP, Chang DT, Raman SP, Hacker-Prietz A, Su Z, Pai J, Oteiza KE, Griffith ME, Wahl RL, Tryggestad E, Pawlik T, Laheru DA, Wolfgang CL, Koong AC, Herman JM. Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2014;89:539-46. [PMID: 24751410 DOI: 10.1016/j.ijrobp.2014.02.031] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
17 Jha P, Bijan B, Melendres G, Shelton DK. Hybrid imaging for pancreatic malignancy: clinical applications, merits, limitations, and pitfalls. Clin Nucl Med 2015;40:206-13. [PMID: 25608151 DOI: 10.1097/RLU.0000000000000677] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
18 Bowen SR, Nyflot MJ, Gensheimer M, Hendrickson KR, Kinahan PE, Sandison GA, Patel SA. Challenges and opportunities in patient-specific, motion-managed and PET/CT-guided radiation therapy of lung cancer: review and perspective. Clin Transl Med 2012;1:18. [PMID: 23369522 DOI: 10.1186/2001-1326-1-18] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
19 Gauthé M, Richard-Molard M, Cacheux W, Michel P, Jouve JL, Mitry E, Alberini JL, Lièvre A; Fédération Francophone de Cancérologie Digestive (FFCD). Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers. Dig Liver Dis 2015;47:443-54. [PMID: 25766918 DOI: 10.1016/j.dld.2015.02.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
20 Vriens D, Disselhorst JA, Oyen WJ, de Geus-Oei LF, Visser EP. Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET. Int J Radiat Oncol Biol Phys 2012;82:e725-31. [PMID: 22330998 DOI: 10.1016/j.ijrobp.2011.11.039] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
21 Abd-Elgaliel WR, Cruz-Monserrate Z, Logsdon CD, Tung CH. Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe. Mol Biosyst 2011;7:3207-13. [PMID: 21935563 DOI: 10.1039/c1mb05215b] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
22 Shao T, Yu L, Li Y, Chen M. [Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi 2015;18:155-60. [PMID: 25800571 DOI: 10.3779/j.issn.1009-3419.2015.03.05] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
23 Wang Z, Gao H, Zhang Y, Liu G, Niu G, Chen X. Functional ferritin nanoparticles for biomedical applications. Front Chem Sci Eng 2017;11:633-46. [PMID: 29503759 DOI: 10.1007/s11705-017-1620-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 8.6] [Reference Citation Analysis]
24 Paulus DH, Oehmigen M, Grueneisen J, Umutlu L, Quick HH. Whole-body hybrid imaging concept for the integration of PET/MR into radiation therapy treatment planning. Phys Med Biol 2016;61:3504-20. [DOI: 10.1088/0031-9155/61/9/3504] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
25 Abdalla AME, Xiao L, Ouyang C, Yang G. Engineered nanoparticles: thrombotic events in cancer. Nanoscale 2014;6:14141-52. [DOI: 10.1039/c4nr04825c] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zhu A, Marcus DM, Shu HK, Shim H. Application of metabolic PET imaging in radiation oncology. Radiat Res 2012;177:436-48. [PMID: 22339451 DOI: 10.1667/rr2702.1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
27 Jelercic S, Rajer M. The role of PET-CT in radiotherapy planning of solid tumours. Radiol Oncol 2015;49:1-9. [PMID: 25810695 DOI: 10.2478/raon-2013-0071] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
28 Grkovski M, Schwartz J, Rimner A, Schöder H, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA. Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer. EJNMMI Res 2016;6:79. [PMID: 27822900 DOI: 10.1186/s13550-016-0210-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
29 Trakul N, Koong AC, Maxim PG, Chang DT. Modern radiation therapy techniques for pancreatic cancer. Gastroenterol Clin North Am 2012;41:223-35. [PMID: 22341260 DOI: 10.1016/j.gtc.2011.12.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
30 Shi J, Li J, Li F, Zhang Y, Guo Y, Wang W, Wang J. Comparison of the Gross Target Volumes Based on Diagnostic PET/CT for Primary Esophageal Cancer. Front Oncol 2021;11:550100. [PMID: 33718127 DOI: 10.3389/fonc.2021.550100] [Reference Citation Analysis]
31 Thorwarth D, Geets X, Paiusco M. Physical radiotherapy treatment planning based on functional PET/CT data. Radiotherapy and Oncology 2010;96:317-24. [DOI: 10.1016/j.radonc.2010.07.012] [Cited by in Crossref: 84] [Cited by in F6Publishing: 66] [Article Influence: 7.0] [Reference Citation Analysis]
32 Shyn PB, Tatli S, Sainani NI, Morrison PR, Habbab F, Catalano P, Silverman SG. Minimizing Image Misregistration during PET/CT–guided Percutaneous Interventions with Monitored Breath-hold PET and CT Acquisitions. Journal of Vascular and Interventional Radiology 2011;22:1287-92. [DOI: 10.1016/j.jvir.2011.06.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
33 Soufi M, Kamali-Asl A, Geramifar P, Rahmim A. A Novel Framework for Automated Segmentation and Labeling of Homogeneous Versus Heterogeneous Lung Tumors in [18F]FDG-PET Imaging. Mol Imaging Biol 2017;19:456-68. [PMID: 27770402 DOI: 10.1007/s11307-016-1015-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
34 Kretzschmar M, Wiewiorski M, Rasch H, Jacob AL, Bilecen D, Walter MA, Valderrabano V. 99mTc-DPD-SPECT/CT predicts the outcome of imaging-guided diagnostic anaesthetic injections: A prospective cohort study. European Journal of Radiology 2011;80:e410-5. [DOI: 10.1016/j.ejrad.2010.09.013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
35 Bibault JE, Oudoux A, Durand-Labrunie J, Mirabel X, Lartigau É, Kolesnikov-Gauthier H. [Positron emission tomography and stereotactic body radiation therapy for lung cancer: From treatment planning to response evaluation]. Cancer Radiother 2015;19:790-4; quiz 795-9. [PMID: 26476702 DOI: 10.1016/j.canrad.2015.05.027] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
36 Lambrecht M, Haustermans K. Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors. Radiotherapy and Oncology 2010;96:339-46. [DOI: 10.1016/j.radonc.2010.07.019] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
37 Tuli R, Surmak A, Reyes J, Hacker-Prietz A, Armour M, Leubner A, Blackford A, Tryggestad E, Jaffee EM, Wong J, Deweese TL, Herman JM. Development of a novel preclinical pancreatic cancer research model: bioluminescence image-guided focal irradiation and tumor monitoring of orthotopic xenografts. Transl Oncol 2012;5:77-84. [PMID: 22496923 DOI: 10.1593/tlo.11316] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
38 Picchio M, Giovannini E, Passoni P, Busnardo E, Landoni C, Giovacchini G, Bettinardi V, Crivellaro C, Gianolli L, Di Muzio N, Messa C. Role of PET/CT in the Clinical Management of Locally Advanced Pancreatic Cancer. Tumori 2012;98:643-51. [DOI: 10.1177/030089161209800516] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Torres Espallardo I. PET/CT: underlying physics, instrumentation, and advances. Radiologia 2017;59:431-45. [PMID: 28089381 DOI: 10.1016/j.rx.2016.10.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
40 Gillman A, Smith J, Thomas P, Rose S, Dowson N. PET motion correction in context of integrated PET/MR: Current techniques, limitations, and future projections. Med Phys 2017;44:e430-45. [DOI: 10.1002/mp.12577] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
41 McKay MJ, Taubman KL, Foroudi F, Lee ST, Scott AM. Molecular Imaging Using PET/CT for Radiation Therapy Planning for Adult Cancers: Current Status and Expanding Applications. Int J Radiat Oncol Biol Phys 2018;102:783-91. [PMID: 30353883 DOI: 10.1016/j.ijrobp.2018.03.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
42 Wahl RL, Herman JM, Ford E. The promise and pitfalls of positron emission tomography and single-photon emission computed tomography molecular imaging-guided radiation therapy. Semin Radiat Oncol 2011;21:88-100. [PMID: 21356477 DOI: 10.1016/j.semradonc.2010.11.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
43 Gkika E, Oehlke O, Bunea H, Wiedenmann N, Adebahr S, Nestle U, Zamboglou C, Kirste S, Fennell J, Brunner T, Gainey M, Baltas D, Langer M, Urbach H, Bock M, Meyer PT, Grosu A. Biological imaging for individualized therapy in radiation oncology: part II medical and clinical aspects. Future Oncology 2018;14:751-69. [DOI: 10.2217/fon-2017-0465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
44 Cyran CC, Paprottka PM, Eisenblätter M, Clevert DA, Rist C, Nikolaou K, Lauber K, Wenz F, Hausmann D, Reiser MF, Belka C, Niyazi M. Visualization, imaging and new preclinical diagnostics in radiation oncology. Radiat Oncol 2014;9:3. [PMID: 24387195 DOI: 10.1186/1748-717X-9-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
45 Werner-Wasik M, Nelson AD, Choi W, Arai Y, Faulhaber PF, Kang P, Almeida FD, Xiao Y, Ohri N, Brockway KD, Piper JW, Nelson AS. What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom. Int J Radiat Oncol Biol Phys 2012;82:1164-71. [PMID: 21531085 DOI: 10.1016/j.ijrobp.2010.12.055] [Cited by in Crossref: 128] [Cited by in F6Publishing: 125] [Article Influence: 11.6] [Reference Citation Analysis]
46 Russo P, Larobina M, Di Lillo F, Del Vecchio S, Mettivier G. Combined SPECT/CT and PET/CT for breast imaging. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 2016;809:58-66. [DOI: 10.1016/j.nima.2015.10.071] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
47 Visioni A, Kim J. Positron emission tomography for benign and malignant disease. Surg Clin North Am 2011;91:249-66. [PMID: 21184913 DOI: 10.1016/j.suc.2010.10.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
48 Paulus DH, Quick HH. Hybrid Positron Emission Tomography/Magnetic Resonance Imaging: Challenges, Methods, and State of the Art of Hardware Component Attenuation Correction. Invest Radiol 2016;51:624-34. [PMID: 27175550 DOI: 10.1097/RLI.0000000000000289] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
49 Fiorentino A, Laudicella R, Ciurlia E, Annunziata S, Lancellotta V, Mapelli P, Tuscano C, Caobelli F, Evangelista L, Marino L, Quartuccio N, Fiore M, Borghetti P, Chiaravalloti A, Ricci M, Desideri I, Alongi P; AIRO Giovani - Italian Association of Radiation Oncology-Young Members and AIMN -Italian Association of Nuclear Medicine- Young Members Working Group. Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2. Crit Rev Oncol Hematol 2019;139:117-24. [PMID: 30940428 DOI: 10.1016/j.critrevonc.2019.03.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
50 Dibble EH, Karantanis D, Mercier G, Peller PJ, Kachnic LA, Subramaniam RM. PET/CT of cancer patients: part 1, pancreatic neoplasms. AJR Am J Roentgenol. 2012;199:952-967. [PMID: 23096166 DOI: 10.2214/ajr.11.8182] [Cited by in Crossref: 71] [Cited by in F6Publishing: 25] [Article Influence: 7.9] [Reference Citation Analysis]
51 Katoh N, Yasuda K, Shiga T, Hasegawa M, Onimaru R, Shimizu S, Bengua G, Ishikawa M, Tamaki N, Shirato H. A New Brain Positron Emission Tomography Scanner With Semiconductor Detectors for Target Volume Delineation and Radiotherapy Treatment Planning in Patients With Nasopharyngeal Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2012;82:e671-6. [DOI: 10.1016/j.ijrobp.2011.09.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
52 Bowen SR, Nyflot MJ, Herrmann C, Groh CM, Meyer J, Wollenweber SD, Stearns CW, Kinahan PE, Sandison GA. Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study. Phys Med Biol 2015;60:3731-46. [PMID: 25884892 DOI: 10.1088/0031-9155/60/9/3731] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
53 Abdoli M, Dierckx RA, Zaidi H. Contourlet-based active contour model for PET image segmentation. Med Phys 2013;40:082507. [PMID: 23927352 DOI: 10.1118/1.4816296] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
54 Guo Y, Li J, Zhang P, Shao Q, Xu M, Li Y. Comparative evaluation of target volumes defined by deformable and rigid registration of diagnostic PET/CT to planning CT in primary esophageal cancer. Medicine (Baltimore) 2017;96:e5528. [PMID: 28072693 DOI: 10.1097/MD.0000000000005528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
55 Riegel AC, Bucci MK, Mawlawi OR, Ahmad M, Luo D, Chandler A, Pan T. Defining internal target volume using positron emission tomography for radiation therapy planning of moving lung tumors. J Appl Clin Med Phys 2014;15:4600. [PMID: 24423860 DOI: 10.1120/jacmp.v15i1.4600] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
56 Takahashi S, Anada M, Kinoshita T, Nishide T, Shibata T. Differences in gross tumor volumes for pancreatic cancer: a comparison of ungated positron emission tomography and contrast-enhanced four-dimensional computed tomography. Jpn J Radiol 2019;37:336-40. [DOI: 10.1007/s11604-019-00812-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Pietsch C, de Galiza Barbosa F, Hüllner MW, Schmid DT, Haerle SK, Huber GF, Studer G, Hany TF, Veit-Haibach P. Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study. BMC Med Imaging 2015;15:60. [PMID: 26714448 DOI: 10.1186/s12880-015-0102-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
58 Scripes PG, Yaparpalvi R. Technical Aspects of Positron Emission Tomography/Computed Tomography in Radiotherapy Treatment Planning. Seminars in Nuclear Medicine 2012;42:283-8. [DOI: 10.1053/j.semnuclmed.2012.04.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
59 Lin Q, Qi Q, Hou S, Chen Z, Jiang N, Zhang L, Lin C. Application of Pet-CT Fusion Deep Learning Imaging in Precise Radiotherapy of Thyroid Cancer. J Healthc Eng 2021;2021:2456429. [PMID: 34413967 DOI: 10.1155/2021/2456429] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Lin C, Kume K, Mori T, Martinez ME, Okazawa H, Kiyono Y. Predictive Value of Early-Stage Uptake of 3'-Deoxy-3'-18F-Fluorothymidine in Cancer Cells Treated with Charged Particle Irradiation. J Nucl Med 2015;56:945-50. [PMID: 25766892 DOI: 10.2967/jnumed.114.152983] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
61 Jin S, Li D, Wang H, Yin Y. Registration of PET and CT images based on multiresolution gradient of mutual information demons algorithm for positioning esophageal cancer patients. J Appl Clin Med Phys 2013;14:3931. [PMID: 23318381 DOI: 10.1120/jacmp.v14i1.3931] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
62 Duan H, Baratto L, Laudicella R, Stracuzzi F, Baldari S, Iagaru A. Molecular imaging of pancreatic neoplasms. Clin Transl Imaging 2021;9:141-51. [DOI: 10.1007/s40336-020-00408-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Rudra S, Narang AK, Pawlik TM, Wang H, Jaffee EM, Zheng L, Le DT, Cosgrove D, Hruban RH, Fishman EK, Tuli R, Laheru DA, Wolfgang CL, Diaz LA Jr, Herman JM. Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation. Pract Radiat Oncol 2012;2:77-85. [PMID: 23585823 DOI: 10.1016/j.prro.2011.06.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
64 Sayre GA, Franc BL, Seo Y. Patient-Specific Method of Generating Parametric Maps of Patlak K(i) without Blood Sampling or Metabolite Correction: A Feasibility Study. Int J Mol Imaging 2011;2011:185083. [PMID: 21912742 DOI: 10.1155/2011/185083] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
65 Zhang Y, Hu J, Li J, Wang N, Li W, Zhou Y, Liu J, Wei L, Shi M, Wang S, Wang J, Li X, Ma W. Comparison of imaging-based gross tumor volume and pathological volume determined by whole-mount serial sections in primary cervical cancer. Onco Targets Ther 2013;6:917-23. [PMID: 23888117 DOI: 10.2147/OTT.S43264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
66 Wagner H. Non–Small Cell Lung Cancer. Clinical Radiation Oncology. Elsevier; 2012. pp. 805-38. [DOI: 10.1016/b978-1-4377-1637-5.00042-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
67 Dewalle-vignion A, Yeni N, Petyt G, Verscheure L, Huglo D, Béron A, Adib S, Lion G, Vermandel M. Evaluation of PET volume segmentation methods: comparisons with expert manual delineations. Nuclear Medicine Communications 2012;33:34-42. [DOI: 10.1097/mnm.0b013e32834d736f] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
68 Herman JM, Regine WF. Adjuvant pancreatic cancer therapy: no one should go it alone or be left behind. Int J Radiat Oncol Biol Phys 2010;77:645-7. [PMID: 20510192 DOI: 10.1016/j.ijrobp.2009.11.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
69 Miner RC. Image-Guided Neurosurgery. J Med Imaging Radiat Sci 2017;48:328-35. [PMID: 31047466 DOI: 10.1016/j.jmir.2017.06.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
70 Hapdey S, Edet-sanson A, Gouel P, Martin B, Modzelewski R, Baron M, Berghian A, Forestier-lebreton F, Georgescu D, Picquenot J, Gardin I, Dubray B, Vera P. Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patients. Radiotherapy and Oncology 2014;112:407-12. [DOI: 10.1016/j.radonc.2014.08.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
71 Patel C, Goldstone A, Chowdhury F, Scarsbrook A. FDG PET/CT in oncology: “raising the bar”. Clinical Radiology 2010;65:522-35. [DOI: 10.1016/j.crad.2010.01.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
72 Xiao L, Liu N, Zhang G, Zhang H, Gao S, Fu Z, Wang S, Yu Q, Yu J, Yuan S. Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer. PLoS One 2017;12:e0170901. [PMID: 28125698 DOI: 10.1371/journal.pone.0170901] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
73 McGurk RJ, Bowsher J, Lee JA, Das SK. Combining multiple FDG-PET radiotherapy target segmentation methods to reduce the effect of variable performance of individual segmentation methods. Med Phys 2013;40:042501. [PMID: 23556917 DOI: 10.1118/1.4793721] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
74 Lee JA. Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology. Radiother Oncol 2010;96:302-7. [PMID: 20708286 DOI: 10.1016/j.radonc.2010.07.003] [Cited by in Crossref: 123] [Cited by in F6Publishing: 100] [Article Influence: 10.3] [Reference Citation Analysis]
75 Kadhim LA, Dholakia AS, Herman JM, Wahl RL, Chaudhry MA. The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma. J Radiat Oncol 2013;2:341-52. [PMID: 29423019 DOI: 10.1007/s13566-013-0130-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
76 Das SK, Ten Haken RK. Functional and molecular image guidance in radiotherapy treatment planning optimization. Semin Radiat Oncol 2011;21:111-8. [PMID: 21356479 DOI: 10.1016/j.semradonc.2010.10.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
77 Chen C, Yan LM, Guo KY, Wang YJ, Zou F, Gu WW, Tang H, Li YL, Wu SJ. The diagnostic value of 18F-FDG-PET/CT in hematopoietic radiation toxicity: a Tibet minipig model. J Radiat Res 2012;53:537-44. [PMID: 22843618 DOI: 10.1093/jrr/rrs006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
78 Unterrainer M, Eze C, Ilhan H, Marschner S, Roengvoraphoj O, Schmidt-Hegemann NS, Walter F, Kunz WG, Rosenschöld PMA, Jeraj R, Albert NL, Grosu AL, Niyazi M, Bartenstein P, Belka C. Recent advances of PET imaging in clinical radiation oncology. Radiat Oncol 2020;15:88. [PMID: 32317029 DOI: 10.1186/s13014-020-01519-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
79 Tao Y, Daly-schveitzer N, Lusinchi A, Bourhis J. Advances in radiotherapy of head and neck cancers. Current Opinion in Oncology 2010;22:194-9. [DOI: 10.1097/cco.0b013e3283388906] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
80 Murphy JD, La TH, Chu K, Quon A, Fischbein NJ, Maxim PG, Graves EE, Loo BW Jr, Le QT. Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2011;80:514-21. [PMID: 20646870 DOI: 10.1016/j.ijrobp.2010.01.057] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
81 Kagadis GC, Katsanos K, Karnabatidis D, Loudos G, Nikiforidis GC, Hendee WR. Emerging technologies for image guidance and device navigation in interventional radiology. Med Phys 2012;39:5768-81. [PMID: 22957641 DOI: 10.1118/1.4747343] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
82 Somer EJ, Pike LC, Marsden PK. Recommendations for the use of PET and PET-CT for radiotherapy planning in research projects. Br J Radiol 2012;85:e544-8. [PMID: 22374274 DOI: 10.1259/bjr/46048428] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
83 Panda A, Garg I, Johnson GB, Truty MJ, Halfdanarson TR, Goenka AH. Molecular radionuclide imaging of pancreatic neoplasms. The Lancet Gastroenterology & Hepatology 2019;4:559-70. [DOI: 10.1016/s2468-1253(19)30081-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
84 Trakul N, Koong AC, Chang DT. Stereotactic body radiotherapy in the treatment of pancreatic cancer. Semin Radiat Oncol. 2014;24:140-147. [PMID: 24635871 DOI: 10.1016/j.semradonc.2013.11.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
85 Yang F, Young L, Yang Y. Quantitative imaging: Erring patterns in manual delineation of PET-imaged lung lesions. Radiother Oncol 2019;141:78-85. [PMID: 31495515 DOI: 10.1016/j.radonc.2019.08.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Lopez Guerra JL, Isa N, Kim MM, Bourgier C, Marsiglia H. New perspectives in radiation oncology: Young radiation oncologist point of view and challenges. Rep Pract Oncol Radiother 2012;17:251-4. [PMID: 24669303 DOI: 10.1016/j.rpor.2012.07.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
87 Kesner A, Pan T, Zaidi H. Data-driven motion correction will replace motion-tracking devices in molecular imaging-guided radiation therapy treatment planning. Med Phys 2018. [PMID: 29679489 DOI: 10.1002/mp.12928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
88 Jan S, Benoit D, Becheva E, Carlier T, Cassol F, Descourt P, Frisson T, Grevillot L, Guigues L, Maigne L, Morel C, Perrot Y, Rehfeld N, Sarrut D, Schaart DR, Stute S, Pietrzyk U, Visvikis D, Zahra N, Buvat I. GATE V6: a major enhancement of the GATE simulation platform enabling modelling of CT and radiotherapy. Phys Med Biol 2011;56:881-901. [DOI: 10.1088/0031-9155/56/4/001] [Cited by in Crossref: 482] [Cited by in F6Publishing: 291] [Article Influence: 43.8] [Reference Citation Analysis]
89 Tamal M. Intensity threshold based solid tumour segmentation method for Positron Emission Tomography (PET) images: A review. Heliyon 2020;6:e05267. [PMID: 33163642 DOI: 10.1016/j.heliyon.2020.e05267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]